Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Digestive Neuroendocrine Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Not applicableStudy completedNCT04753229
What this trial is testing

Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia

Who this might be right for
Neuroendocrine Tumors
Institut Paoli-Calmettes 50
Early research (Phase 1)Study completedNCT03411915
What this trial is testing

XmAb®18087 in Subjects With NET and GIST

Who this might be right for
Neuroendocrine TumorGastrointestinal Neoplasm
Xencor, Inc. 62
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619898
What this trial is testing

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

Who this might be right for
ColitisHepatitisMelanoma (Skin Cancer)
Therakos LLC 112
Testing effectiveness (Phase 2)Ended earlyNCT02554812
What this trial is testing

Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Who this might be right for
Advanced Cancer
Pfizer 409
Not applicableLooking for participantsNCT04498767
What this trial is testing

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

Who this might be right for
Gynecologic CancerSkin CancerHead and Neck Cancer+12 more
European Organisation for Research and Treatment of Cancer - EORTC 200
Not applicableLooking for participantsNCT06881511
What this trial is testing

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

Who this might be right for
Autoimmune Gastritis
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Testing effectiveness (Phase 2)Looking for participantsNCT04851119
What this trial is testing

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Who this might be right for
Colorectal CarcinomaEndometrial CarcinomaMelanoma+19 more
Children's Oncology Group 147
Not applicableEnded earlyNCT00730483
What this trial is testing

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorMetastatic Cancer
Yale University 13
Testing effectiveness (Phase 2)Ended earlyNCT00084461
What this trial is testing

Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+7 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Ended earlyNCT01374451
What this trial is testing

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Who this might be right for
Islet Cell Tumor
Novartis Pharmaceuticals 160
Early research (Phase 1)Ended earlyNCT04254107
What this trial is testing

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Who this might be right for
Non-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction Carcinoma+9 more
Seagen Inc. 133
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Early research (Phase 1)Looking for participantsNCT03454035
What this trial is testing

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Who this might be right for
Tumor, SolidPancreatic CancerMelanoma
UNC Lineberger Comprehensive Cancer Center 45
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Looking for participantsNCT02185443
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Who this might be right for
Liver MetastasesColorectal CancerAnal Canal Cancer+1 more
University of Sao Paulo 43
Early research (Phase 1)Active Not RecruitingNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Next Page